Skip to Main Content

Connie Newman, MD

Adjunct Professor, Department of Medicine

statins, randomized controlled trials, statin safety

My main interests are statin safety and intolerance and the effects of statins on cardiovascular disease. I have designed, conducted, and analyzed efficacy and safety data from large cardiovascular outcomes trials of statins in various populations, including patients with diabetes, stroke or transient ischemic attack (TIA), cardiovascular disease, and chronic kidney disease.

My research has involved the following:

  • evaluating the effects of atorvastatin 10 mg on heart attacks and stroke in about 2,500 patients with diabetes, as part of the steering committee of the Collaborative Atorvastatin Diabetes Study (CARDS)
  • analyzing safety data from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine, or SEARCH, and the Study of Heart and Renal Protection, or SHARP
  • performing meta-analyses of safety data from trials of statins, including a meta-analysis of cancer events and deaths in 27 randomized controlled trials of various statins in about 170,000 patients and meta-analyses of safety data from early clinical trials of atorvastatin
  • serving as a member of the Cholesterol Treatment Trialists’ Collaboration

In addition, I was a member of the steering committee of the Biochemical Efficacy and Safety Trial of Vitamin D, or BEST-D. This randomized double-blind trial in people older than 65 years evaluated the effects of one year of vitamin D treatment at either 4,000 IU or 2,000 IU per day, compared with placebo. Outcomes measured included levels of vitamin D, parathyroid hormone, and calcium; other safety parameters; and selected cardiovascular endpoints such as arterial stiffness, blood pressure, and lipids.

I am currently chair of the task force for the Endocrine Society’s clinical practice guideline on lipid management in patients with endocrine disorders, including type 1 and type 2 diabetes.

Previously, I studied mammary gland growth and development and the role of novel pituitary factors in primate and rodent models. My earlier clinical research focused on new therapies for the treatment of pituitary tumors, including the effects of somatostatin analogues in patients with acromegaly. I have also investigated the effects of growth hormone replacement on cardiopulmonary function in growth-hormone–deficient adults.

Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

MD from Cornell University

Fellowship, Columbia University College of Physicians and Surgeons, Endocrinology and Metabolism

Residency, Beth Israel Medical Center, New York, NY, Internal Medicine

Newman, Connie B; Tobert, Jonathan A

Journal of clinical endocrinology & metabolism. 2023 Mar 10; 108(4):784-790

Newman, Connie B

Endocrinology & metabolism clinics of North America. 2022 Sep; 51(3):655-679

Neves, João Sérgio; Newman, Connie; Bostrom, John A; Buysschaert, Martin; Newman, Jonathan D; Medina, José Luiz; Goldberg, Ira J; Bergman, Michael

Diabetes research & clinical practice. 2022 Jul 03; 190:109980

Kling, Juliana M; Sleeper, Rebecca; Chin, Eliza Lo; Rojek, Mary K; McGregor, Alyson J; Richards, Lorie; Mitchell, Ann Bradley; Stasiuk, Christina; Templeton, Kimberly; Prasad, Joanne; Pfister, Sandra; Newman, Connie B

Journal of women's health (Larchmont, N.Y. : 2002). 2022 Jul; 31(7):905-910

Buck, Ashley N; Shultz, Sarah P; Huffman, Katie F; Vincent, Heather K; Batsis, John A; Newman, Connie B; Beresic, Nicholas; Abbate, Lauren M; Callahan, Leigh F

Current developments in nutrition. 2022 Jun; 6(6):nzac084

Newman, Connie B

Best practice & research. Clinical endocrinology & metabolism. 2022 May 10; 101667

Newman, Connie; Henderson, Cassandra; Laraque-Arena, Danielle

Journal of the National Medical Association. 2022 Feb; 114(1):42-46

Thomas, Ynhi T; Newman, Connie B; Faynshtayn, Nina G; McGregor, Alyson J

Clinical therapeutics. 2022 Jan; 44(1):23-32